Specialized Hydrocortisone Formulations for Extreme Environments and High-Security Needs

Publication ID: 24-11857555_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Hydrocortisone Formulations for Extreme Environments and High-Security Needs,” Published Technical Disclosure No. 24-11857555_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857555_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,555.

Summary of the Inventive Concept

Adapted hydrocortisone formulations for disaster relief, high-security, and extreme weather conditions, providing targeted solutions for unique operational environments

Background and Problem Solved

The original patent described an aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol. However, these formulations may not be suitable for extreme environments or high-security needs. The inventive concept addresses this limitation by adapting the formulation for disaster relief, high-security environments, and extreme weather conditions.

Detailed Description of the Inventive Concept

The inventive concept comprises adapted aqueous pharmaceutical formulations of hydrocortisone sodium phosphate and monothioglycerol, packaged in portable, waterproof containers or secure, tamper-evident containers for high-security environments. The formulations are sterilized and designed for use in extreme temperatures, making them suitable for disaster relief and emergency response situations. The inventive concept also includes a pharmaceutical kit for emergency responders, a portable, handheld device for administering the formulation, and a system for remote medical treatment via telemedicine.

Novelty and Inventive Step

The new claims provide a novel and non-obvious adaptation of the original formulation, addressing the specific needs of extreme environments and high-security situations. The inventive step lies in the combination of the original formulation with specialized packaging, sterilization, and delivery systems tailored to these unique operational environments.

Alternative Embodiments and Variations

Alternative embodiments may include adapting the formulation for use in space exploration, search and rescue operations, or other extreme environments. Variations may include different packaging materials, sterilization methods, or delivery systems to further tailor the formulation to specific needs.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical, disaster relief, and high-security industries. Target markets may include government agencies, emergency responders, and private companies operating in extreme environments.

Original Patent Information

Patent NumberUS 11,857,555
TitleAqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol
Assignee(s)Antares Pharma, Inc.